Last reviewed · How we verify

Amlodipine besylate controlled-release tablets

Overseas Pharmaceuticals, Ltd. · Phase 1 active Small molecule

Amlodipine besylate controlled-release tablets is a Small molecule drug developed by Overseas Pharmaceuticals, Ltd.. It is currently in Phase 1 development.

At a glance

Generic nameAmlodipine besylate controlled-release tablets
SponsorOverseas Pharmaceuticals, Ltd.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Amlodipine besylate controlled-release tablets

What is Amlodipine besylate controlled-release tablets?

Amlodipine besylate controlled-release tablets is a Small molecule drug developed by Overseas Pharmaceuticals, Ltd..

Who makes Amlodipine besylate controlled-release tablets?

Amlodipine besylate controlled-release tablets is developed by Overseas Pharmaceuticals, Ltd. (see full Overseas Pharmaceuticals, Ltd. pipeline at /company/overseas-pharmaceuticals-ltd).

What development phase is Amlodipine besylate controlled-release tablets in?

Amlodipine besylate controlled-release tablets is in Phase 1.

Related